0001145549-24-001612.txt : 20240110 0001145549-24-001612.hdr.sgml : 20240110 20240110104213 ACCESSION NUMBER: 0001145549-24-001612 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231031 FILED AS OF DATE: 20240110 DATE AS OF CHANGE: 20240110 EFFECTIVENESS DATE: 20240110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHN HANCOCK PREMIUM DIVIDEND FUND CENTRAL INDEX KEY: 0000855886 ORGANIZATION NAME: IRS NUMBER: 043097281 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-05908 FILM NUMBER: 24525343 BUSINESS ADDRESS: STREET 1: C/O JOHN HANCOCK FUNDS STREET 2: 200 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-663-3000 MAIL ADDRESS: STREET 1: C/O JOHN HANCOCK FUNDS STREET 2: 200 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: HANCOCK JOHN PATRIOT PREMIUM DIVIDEND FUND II DATE OF NAME CHANGE: 19990518 FORMER COMPANY: FORMER CONFORMED NAME: PATRIOT PREMIUM DIVIDEND FUND II DATE OF NAME CHANGE: 19920703 N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000855886 XXXXXXXX true false false N-2 John Hancock Premium Dividend Fund 811-05908 0000855886 549300HU07GPOB5DR949 200 Berkeley Street Boston 02116 US-MA US 6176634497 State Street Bank and Trust Company One Congress Street Boston 02114 6177863000 SSB maintains the accounting records and the custody of the assets. John Hancock Premium Dividend Fund 200 Berkeley Street Boston 02116 6176634497 Records related to its functions as Registrant John Hancock Investment Management LLC 200 Berkeley Street Boston 02116 6176632430 Records related to its functions as advisor Manulife Investment Management (US) LLC 197 Clarendon Street Boston 02216 6173751876 Records related to its functions as sub-advisor N N N-2 Y Hassell H. McClellan N/A N James R. Boyle N/A N William H. Cunningham N/A N Grace K. Fey N/A N Deborah C. Jackson N/A N Gregory A. Russo N/A N Steven R. Pruchansky N/A N Andrew G. Arnott N/A Y Frances G. Rathke N/A N Noni L. Ellison N/A N Dean C. Garfield N/A N Paul Lorentz N/A Y Trevor Swanberg 004213623 200 Berkeley Street Boston 02116 XXXXXX N N N N N John Hancock Investment Management Distributors LLC 8-43582 000028262 N/A Y N PricewaterhouseCoopers LLP 00238 5493002GVO7EO8RNNS37 N N N N N N John Hancock Premium Dividend Fund 549300HU07GPOB5DR949 N N/A N N Y N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N N/A 191181846.000000000000 0.000000000000 Rule 12d1-1 (17 CFR 270.12d1-1) Rule 23c-1 (17 CFR 270.23c-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4 (17 CFR 270.18f-4) Rule 18f-4(d)(ii) (17 CFR 270.18f-4(d)(ii)) Y Y N N John Hancock Investment Management LLC 801-8124 000105790 AOWFNEEIG2OJ03AZXK87 N Manulife Investment Management (US) LLC 801-42023 000106435 549300ZKXV1OCZQWDK34 Y N Computershare Inc 084-05925 254900Y7PP3ZED9AUY94 N N N Refinitiv 549300561UZND4C7B569 CA N ICE Data Services 5493000NQ9LYLDBCTL34 N Pricing Direct 549300WIC0TOJ7N7GD54 N S&P Global Market Intelligence Y6X4K52KMJMZE7I7MY94 GB N Bloomberg LP 5493001KJTIIGC8Y1R12 N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Computershare Shareowner Services, LLC 254900Y7PP3ZED9AUY94 N N N John Hancock Investment Management LLC AOWFNEEIG2OJ03AZXK87 Y N N John Hancock Investment Management Distributors LLC 8-43582 000028262 N/A 0.000000000000 Merrill Lynch, Pierce, Fenner & Smith Incorporated 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 36150.000000000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 24758.610000000000 National Financial Services LLC 8-26740 000013041 549300JRHF1MHHWUAW04 19857.570000000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 18830.640000000000 Pershing LLC 8-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 11982.540000000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 10650.000000000000 Cantor Fitzgerald & Co. 8-201 000000134 5493004J7H4GCPG6OB62 9110.350000000000 UBS AG N/A N/A BFM8T61CT2L1QCEMIK50 CH 7103.140000000000 Jefferies LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 6750.000000000000 Sanford C. Bernstein & Co., LLC 8-52942 000104474 549300I7JYZHT7D5CO04 5550.000000000000 169958.870000000000 State Street Global Markets, LLC 8-69862 000285852 549300FDEDF5ORXCMQ56 425857930.720000000000 UBS AG N/A N/A BFM8T61CT2L1QCEMIK50 CH 387099194.710000000000 Merrill Lynch, Pierce, Fenner & Smith Incorporated 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 64311393.000000000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 27549885.390000000000 Cantor Fitzgerald & Co. 8-201 000000134 5493004J7H4GCPG6OB62 26382752.320000000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 25503863.470000000000 Citigroup Global Markets Holdings Inc. 8-8177 000007059 82VOJDD5PTRDMVVMGV31 24892728.800000000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 10185277.800000000000 Royal Bank of Canada N/A N/A ES7IP3U3RHIGC71XBU11 CA 10104639.080000000000 Barclays Bank PLC N/A N/A G5GSEF7VJP5I7OUK5573 GB 9278344.160000000000 1230720328.550000000000 Y 593712826.250000000000 Common stock Common shares N Common stock N N N N 1.470000000000 5.060000000000 9.570000000000 10.580000000000 true INTERNAL CONTROL RPT 2 premiumdividend.htm PDFtoHTML Conversion Output

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of John Hancock Premium Dividend Fund

In planning and performing our audit of the financial statements of John Hancock Premium Dividend Fund (the "Fund") as of and for the year ended October 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to

permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of October 31, 2023.

This report is intended solely for the information and use of the Board of Trustees of John Hancock Premium Dividend Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

December 15, 2023

PricewaterhouseCoopers LLP, 101 Seaport Boulevard, Suite 500, Boston, MA 02210

T: (617) 530 5000, F: (617) 530 5001, www. pwc.com/us